Instrument Inactif

Autres langues Ambrx Biopharma Inc. Nasdaq

Actions

Ambrx Biopharma Inc. Announces Resignation of Andrew Aromando as Chief Operating Officer	12/03
Johnson & Johnson Completes Ambrx Acquisition	07/03
J&J : finalise l'acquisition d'Ambrx Biopharma pour 2 Mds$	07/03
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from NASDAQ Composite Index	07/03
Johnson & Johnson completed the acquisition of Ambrx Biopharma Inc. from a group of shareholders.	07/03
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from S&P Global BMI Index	07/03
Ambrx Biopharma Shareholders Approve Johnson & Johnson Acquisition Deal	06/03
Ambrx Shareholders Approve Acquisition by Johnson & Johnson	06/03
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from NASDAQ Biotechnology Index	06/03
J&J's Acquisition of Ambrx Biopharma Completes Hart-Scott-Rodino Waiting Period	22/02
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update	23/01
North American Morning Briefing : Central Bankers -2-	17/01
North American Morning Briefing : Focus Fixed on -2-	11/01
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	09/01
EN DIRECTO DESDE LOS MERCADOS: Grifols, Airbus, Boeing, Sony, Shell, Nike, Brunello Cucinelli, Samsung, J&J, GSK...	09/01
Bolsa de Madrid: ¡Nvidia ha vuelto!	09/01
Health Care Up as Merger Wave Continues -- Health Care Roundup	09/01
MÄRKTE USA/Dow dreht ins Plus - Nasdaq gewinnt über 2%	08/01
Sector Update: Health Care Stocks Rise Late Afternoon	08/01
Trending : Johnson & Johnson and Merck & Co. Announce Acquisitions	08/01

Aucun résultat pour cette recherche